Avalo Therapeutics stock price
아발로 테라퓨틱스NASDAQ:AVTX · Nasdaq · Healthcare$14.99+0.27%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Avalo Therapeutics last closed at $14.99 (+0.27%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -6.5×. Its overall grade ranks 305 of 739 stocks in Healthcare.
About this company
Avalo Therapeutics last closed at $14.99 (+0.27%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 305/739
Valuation grade B
Related stocks
- AstraZenecaCompetitor
희귀질환·면역/염증 계열 신약 개발에서 경쟁하는 대형 글로벌 제약사
- RocheCompetitor
면역학·종양학 신약 포트폴리오에서 경쟁하는 글로벌 빅파마
- NovartisCompetitor
염증·면역질환 치료제 개발 경쟁사로 규모가 큰 글로벌 제약사
About Avalo Therapeutics
- What technical signals does Avalo Therapeutics (AVTX) have?
- Avalo Therapeutics current technical signals: no active technical signal.
- Is Avalo Therapeutics a cup-and-handle pattern?
- No. Avalo Therapeutics has no valid Cup signal right now.
- What published figures are available for Avalo Therapeutics?
- Market cap: $271.83M. Trailing 12 months PER: -6.5×. Latest quarter PBR: 1.46×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Avalo Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy